Moisés Cukier

Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomes

Julie Hallet, Calvin Law, Moisés Cukier et al. · Cancer · 2014 · 831 citations · Full text

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 280 citations · Full text

Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience

Moisés Cukier, Andrew J. Smith, Laurent Milot et al. · European Journal of Surgical Oncology · 2012 · 73 citations

Single Institution Experience, Surgical Oncology, Neoadjuvant Chemoradiotherapy +12

Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

James Glasbey, Tom Abbott, Adesoji Ademuyiwa et al. · The Lancet · 2022 · 68 citations · Full text

Ki-67 is a reliable pathological grading marker for neuroendocrine tumors

Ashlie Nadler, Moisés Cukier, Corwyn Rowsell et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2013 · 64 citations

Tumor Biology, Medicine, Neuroendocrine Disorder +6